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 Abstract 
Fibroblast growth factors are a family of intercellular signaling 
molecules that participate in the normal growth of the craniofacial 
skeleton. Advances in molecular genetics have revealed that fibroblast 
growth factors are involved in the regulation of bone growth by maintaining 
a balance between the differentiation of osteoblasts and the proliferation 
of mesenchyme (Morriss-Kay and Wilkie, 2005). The focus of my research 
is fibroblast growth factor 20a because it seems to play a significant role in 
the normal development of the skull. At birth, the skull is made up of bony 
elements, that meet at fibrous membranes called sutures. Throughout 
development, those bony elements fuse together at different rates to form 
solid bone. Previous research has shown that zebrafish deficient in fgf20a, 
which are referred to as dob mutants, have abnormal suture patterning 
and exhibit several craniofacial defects that are similar in presentation to 
the defects seen in individuals with craniosynostosis (Albertson, 
unpublished data). Craniosynostosis is a birth defect that is caused by the 
premature closure of sutures and is characterized by an irregular 
craniofacial shape. Using whole mount in situ hybridization (WISH) 
methods and advanced microscopic imaging, I gained insights into the 
pathological mechanisms that lead to aberrant suture formation in 
humans. Our research results suggest that fgf20a directly affects suture 
and skull development. We have demonstrated this in two ways. Firstly, 
we showed that in the absence of fgf20a, zebrafish have abnormal suture 
patterning. Secondly, we showed that the fgf20a gene is normally 
expressed in the cranial sutures of wild-type zebrafish through WISH 
methods. Our results are important because this is the first instance where 
an fgf ligand is implicated in craniosynostosis. Furthermore, we have 
established a molecular foothold (via fgf20a) into skull and suture 
development, and we have established a model system for studying the 
developmental origins and mechanisms of craniosynostosis. 
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Introduction 
Craniosynostosis, a birth defect occurring in 1 of 2,500 live births, is 
characterized by an irregular craniofacial shape that often presents 
challenging clinical problems (Morriss-Kay and Wilkie, 2005). At birth, the 
skull is made of bony elements that gradually fuse together into solid bone 
throughout development. These bony elements meet at sutures, which are 
fibrous membranes, and fuse together at different rates. This mechanism 
allows for the normal expansion of the brain and soft tissues during 
infancy and childhood since a newborn has only forty percent of her adult 
brain volume (Kabbani and Raghuveer, 2004). Craniosynostosis is caused 
by the premature fusion of sutures and this can have detrimental effects 
on the child’s intelligence since brain growth is restricted. The disease 
also results in an abnormal head shape and an increase in intracranial 
pressure that often has devastating physiological consequences (Morris-
Kay and Wilkie, 2005).  
The recent discovery of mutations in FGFR1, FGFR2, and FGFR3 
in syndromic and non-syndromic cases of craniosynostosis has led to the 
hypothesis that the disease involves the failure of the fibroblast growth 
factor signaling system (Morriss-Kay and Wilkie, 2005). Fibroblast growth 
factors are a family of intercellular signaling molecules that are involved in 
cell proliferation, differentiation, and migration during early stages of 
development. They also participate in a wide array of tissue interactions, 
including the growth and development of the craniofacial skeleton.  
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The focus of our research is fibroblast growth factor 20a because it 
seems to play a significant role in suture patterning (Albertson, 
unpublished data). The objectives of our research are to identify the 
anatomical consequences of a null fgf20a mutation, determine at what 
stage of development the defect arises, and to gain a better understanding 
of the pathological mechanisms that lead to the defect.  
 
Anatomy of the Craniofacial Skeleton  
 The mammalian skull vault is made up of the neurocranium, which 
surrounds and protects the brain, and the viscerocranium, which forms the 
face. The skull consists of two frontal bones, two parietal bones, and one 
occipital bone. These bones are joined by five major cranial sutures: 
metopic, sagittal, coronal, lambdoid, and squasomal. Also, newborns have 
an anterior fontanelle and a posterior fontanelle which enable the plates of 
the skull to flex (Morriss-Kay and Wilkie, 2005). Throughout development, 
the sutures and fontanelles close at different times to form one continuous 
plate of bone, but they are still considered pairs of bone because of their 
paired developmental origin (Table 1).  
Table 1- Closure of Sutures and Fontanelles* 
Type of Suture/fontanelle Closure Time 
Metopic Suture Nine months to two years (may 
persist into adulthood) 
Coronal, sagittal, lambdoid sutures 40 years 
Anterior fontanelle Nine to eighteen months 
Posterior fontanelle Three to six months 
*Adapted from Kabbani and Raghuveer, 2004 
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Zebrafish (Danio rerio) are an important emerging model system in 
the study of human diseases and are an appropriate model to study 
craniofacial defects. The anatomy of the zebrafish cranial vault and suture 
patterning is similar to that of mammalian organisms (Figure 1). Also, 
zebrafish produce a large 
number of embryos that are 
transparent and develop 
externally.  We can therefore 
analyze their phenotypic traits 
without using invasive 
techniques and their genetics 
are easily manipulated.  
 
Previous Research 
Previous research in mice has shown that a broad repertoire of 
Fgfs, including fgf20, is expressed in the cranial sutures (Hajihosseini et 
al. 2001) (see Table 2). Furthermore, recent studies in zebrafish have 
shown that a null mutation in fgf20a has several phenotypic consequences 
including an irregular shape of the skull (Albertson, unpublished data). 
Zebrafish that are deficient in fgf20a are known as devoid of blastema, 
dob, mutants because of their inability to regenerate their tail due to the 
loss of blastema cells.  A blastema is a mass of cells that are 
Figure 1- The dorsal view of the wild-type 
zebrafish with normal suture patterning. The 
metapoic (M), sagittal (S), lambdoid (L), and 
coronal (C) sutures are clearly seen. 
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undifferentiated and, thus, are capable of regenerating tissues and organs 
(including the tail fin in fish). 
Table 2- Previous FGF/FGFR Research 
FGF/FGFR Species Tissue(s) Process Mutation 
FGFR1 Mice Sutures Accelerated 
osteoblast 
differentiation 
Mild form of 
Pfeiffer syndrome 
(Morriss-Kay and 
Wilkie, 2005) 
FGFR2 Mice Sutures Premature loss 
of proliferation 
in 
osteoprogenitor 
cells 
Crouzon, Pfeiffer, 
Apert syndromes 
(Wilkie, 1997) 
FGFR3 Mice  Sutures Negative 
regulator of 
endochronal 
ossification 
Growth disorders 
of long bones 
(dwarfism), 
Muenke 
syndrome, and 
rare variant of 
Crouzon 
syndrome (Wilkie, 
1997) 
FGF1 Mice Coronal 
suture 
Cause suture 
obliteration 
and fusion 
(Morriss-Kay 
and Wilkie, 
2005) 
 
FGF2 Mice  Overexpression 
leads to 
increased 
apoptosis 
Chrondrodyspalsia 
(shortened long 
bones) (Rice et al, 
2000) 
FGF4 Mice Embryonic 
osteogenic 
fronts 
Accelerates 
suture closure, 
stimulates cell 
proliferation 
(Rice et al, 
2000) 
 
FGF10 Mice Calvarial 
Sutures 
  
FGF20 Mice Coronal 
sutures and 
limb buds 
Suggests role in 
proliferation, 
differentiation, 
and apoptosis 
(Hajihosseini 
and Heath, 
2002) 
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*Fgfs 3,4,5,6, and 8 are not expressed in cranial sutures 
** In general, undifferentiated (immature) osteoblast cells respond 
to FGF treatment with increased proliferation, whereas in 
differentiating cells FGF causes apoptosis. 
Previous research has also revealed that craniosynostosis is linked 
to fibroblast growth factor receptors, but little is known about the signal 
molecules, ligands, that bind to receptors to trigger cells to proliferate, 
differentiate, and/or migrate (Hajihosseini et al. 2001).Thus, in an effort to 
identify one of the cognate ligands, we examined the expression pattern of 
fibroblast growth factor 20a in the developing zebrafish craniofacial 
skeleton by using polymerase chain reaction (PCR) and whole mount in 
situ hybridization (WISH) methods.  
 
Methods 
Polymerase Chain Reaction 
We genotyped the mutant dob zebrafish by using Polymerase 
Chain Reaction (PCR) and the restriction enzyme, mnl1. PCR primers 
were designed to amplify the fgf20a locus, and mnl1 was chosen because 
it recognizes the mutated form of the gene (see Figure 2). In this way 
homozygous recessive, 
heterozygous and wild-type 
animals could be identified.  
    We extracted the DNA by 
cutting the tip of a zebrafish tail 
and placing it in a microcentrifuge tube with 50 µl of Extraction solution 
Figure 2- The restriction enzyme, mnl1, 
recognizes the sequence CCTC and then 
cuts seven base pairs downstream. 
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and 12.5 µl of Tissue Preparation Solution. We then incubated the tube for 
10 minutes at room temperature and then for 3 minutes at 95°C. Once the 
zebrafish tail had been sufficiently digested, we added 100 µl of 
Neutralization Solution B and mixed thoroughly. We then added 4 µl of 
water, 10 µl of REDExtract-N-Amp PCR Reaction Mix (Sigma-Aldrich, St. 
Louis, MO), 1 µl of Forward Primer (Invitrogen, Carlsbad, CA), 1 µl of 
Reverse primer (Invirtogen, Carlsbad, CA), 4 µl of Tissue Extract and 
mixed gently. The forward and reverse primers used for the amplification 
of the fgf20a locus were CTGTCAGCCGAGTGTGTGTT and 
ACGTCCCATCTTTGTTGAGG, respectively. We then performed thermal 
cycling (see Table 3). 
Table 3- Thermal Cycling  
Step Temperature Time (minutes) Cycles 
Initial 
Denaturation 
94°C 3  1 
Denaturation 94°C 1 35 
Annealing 65°C 1 35 
Extension 72°C 1 35 
Final Extension 72°C 10 1 
Hold 4°C Indefinitely  
*Adapted from Sigma-Aldrich 
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After the DNA was successfully amplified, we then combined 20 µl 
of the PCR product, 3 µl of 10x BSA, 3 µl of #2 Buffer, 3 µl of distilled 
water, and 1 µl of the restriction enzyme, mnl1(NE Biolads, Ipswich, MA) . 
We let the mixture sit overnight at room temperature and then ran the 
digested product on a 5% agarose gel (Figure 3).  
In dob mutants the mnl1 
restriction enzyme cut the 
target sequence resulting in 
three DNA fragments in 
dob/dob individuals 
compared to two fragments in 
wild-type (+/+) individuals. 
The heterozygous carrier of the dob mutation, dob/+, has one allele with 
the fgf20a mutation and one normal allele, so four fragments were formed 
upon the mnl1 digest.  
 
Whole Mount In Situ Hybridization 
Using WISH methods and an antisense fgf20a riboprobe, we were 
able to localize fgf20a mRNA to particular regions of the developing skull. 
We fixed juvenile (64 day) wild-type zebrafish in 4% paraformaldehyde 
(PFA) overnight at 4°C. Then, we dehydrated the embryos by washing 
them with different concentrations of methanol and phosphate buffered 
saline + tween (PBSt). The next day, we rehydrated the embryos by using 
Figure 3- The large DNA fragment in wild-types is cut 
in animals that carry the dob allele.  
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the following protocol: 2 x 10 mins in 50% methanol/ 50% PBSt, 1 x 10 
mins in 25% methanol/ 75% PBSt, 2 x 10 mins PBSt. Then we removed 
the eyes and guts of the juvenile fish and digested the remaining tissue by 
using a 1:5000 dilution of a 50 mg/mL stock of proteinase K+ in PBSt. After 
30 minutes, we rinsed the sample in PBSt and refixed it in 4% PFA for half 
an hour.  
Then, we placed the samples in 1.5 mLs of Prehybridization 
solution (PHS) and put it in a water bath at 70°C for 3 hours. Then, we 
replaced the PHS with 70°C Hybridization solution (HS) plus the riboprobe 
and let it incubate overnight in the water bath. The next day, we performed 
a series of washes at 70°C: 1 x 10mins in 75% PHS/ 25% 2x SSC, 1 x 
10mins in 50% PHS/ 50% 2x SSC, 1 x10mins in 25% PHS/ 75% 2x SSC, 
1 x 10mins in 2x SSC. Then, we dropped the temperature of the waterbath 
to 68°C and washed the sample with 0.2x SSC followed by two washes 
with Maleic Acid Buffer (MAB) at room temperature.  
To block the zebrafish, we moved the specimen to a plate with 2 
mLs of blocking solution at room temperature for three hours. 
Simultaneously, we pre-blocked the anti-DIG antibody in the blocking 
solution. After three hours, we combined the specimen with the anti-DIG 
solution and incubated it at 4°C overnight.  
The next day, we performed another series of washes: 1 x 5mins in 
MAB, 2 x 10mins in MAB, 1 x 30mins in MAB, 1 x 1hr in MAB, 3 x 5mins in 
AP Buffer. Then, we stained the embryos by removing the excess AP 
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Buffer and adding approximately 500 µl of staining solution. We kept the 
sample in a dark room and after 20mins we washed it with 2x 5mins in 
PBSt to stop the reaction. Then, in order to facilitate the clearing of non-
specific staining, we performed the following washes: 1 x 10mins in 25% 
methanol/75% PBSt, 2 x 10mins in 50% methanol/ 50% PBSt, and then 
stored them in 100% methanol overnight at 4°C. The next day, we 
rehydrated the specimens and performed the following glycerol series  in 
order to facilitate clearing: 4hrs 25% glycerol/ 75% PBSt, 6 hrs 50% 
glycerol/ 50% PBSt, and then we stored them in 75% glycerol/ 25% PBSt.   
 
Results  
Identifying the Defect 
By staining wild-type and dob/dob mutant zebrafish with alizarin red, it is 
evident that adult dob mutants have defective suture patterning (Figures 
4-6). 
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Expression of fgf20a in Cranial Sutures 
We used an antisense fgf20a ribroprobe with a purple label to 
localize fgf20a mRNA in situ. Our results from the WISH analyses suggest 
that fgf20a plays a primary role in 
skull and suture development.  
  
 
 
 
 
 
 
Figure 5- The patterning of the sagittal 
suture in dob mutants is irregular 
(dashes lines) as is the shape of the 
Figure 4- The sagittal suture of the wild-type 
zebrafish respects the midline (dashed line), 
and the frontal bone is cone shaped (solid 
line).  
Figure 6- The sagittal suture of this dob 
mutant deviates in several places from 
the midline (dashed lines) and the frontal 
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Conclusion 
Our research results suggest that fgf20a directly affects suture and 
skull development. We have demonstrated this in two ways. Firstly, in the 
absence of fgf20a zebrafish have abnormal suture patterning (Figures 5 
and 6). Secondly, the fgf20a gene is normally expressed in the cranial 
sutures (Figures 7-9). The next step is to determine when this aberrant 
suture pattern arises in the dob mutant. The future direction of our 
research is to compare the craniofacial development in wild-type and dob 
mutant zebrafish at different stages of development. Below is an image of 
a wild-type zebrafish stained with calcein (Fig. 10). Calcein, also known as 
fluorexon, is used to visualize the developing bone in live embryos. 
Calcein binds to free Calcium in the bone matrix, which results in green 
fluorescence under UV light. 
Figure 7- The dorsal view of the 
wild-type zebrafish, in which the 
purple color indicates the 
expression of fgf20a in the anterior 
Figure 8- This is a closer view of the 
fontanelle where fgf20a is obviously 
expressed.  
Figure 9- This is a closer look at the 
suture boundary with putative 
osteoblast cells expressing fgf20a 
(arrows).  
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Our results are important because we have identified a 
developmentally tractable model (zebrafish) to study the developmental 
origins of human craniosynostosis and this model system has proven to 
be very advantageous for understanding human health and disease. Also, 
we have established a molecular foothold (via fgf20a) into skull and suture 
development. 
 
 
 
 
 
 
Figure 10- Image of live larval wild-type zebrafish stained with Calcein and viewed under 
UV light.  
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Figure 11- A lateral view of a zebrafish stained with Alizarin 
red. We have established that zebrafish are an excellent 
model system for studying developmental origins and 
mechanisms of craniosynostosis.   
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Written Capstone Summary 
The Role of Fibroblast Growth Factor 20a in the Craniofacial Development 
of Zebrafish 
 
The development of a multicellular adult organism is dependent on 
the individual’s genetic makeup. Genes are considered the blueprint for 
the human body because they tell the body how to build a specific 
structure. Thus, to understand development, we often study the effect of 
particular genes. The focus of our research project is fibroblast growth 
factor 20a, also known as fgf20a, because it seems to play a significant 
role in the normal development of the skull. Fibroblast growth factors are a 
family of small proteins that bind to receptors on other cells to signal them 
to multiply, differentiate, and/or migrate. Throughout early development, 
cellular specialization and tissue growth are due in large part to the fgf 
intercellular signaling process. Previous research has revealed that many 
human growth defects are linked to defective fgf receptors, including 
craniosynostosis (Morriss-Kay and Wilkie, 2005).  
Craniosynostosis, is a serious birth defect that occurs in 
approximately 1 of 2,500 live births and is characterized by abnormal 
craniofacial shape (Morriss-Kay and Wilkie, 2005). At birth, the skull is 
made of bony elements that gradually fuse together into solid bone 
throughout development. Furthermore, the bony elements meet at 
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sutures, which are fibrous membranes, and fuse together at different 
rates. This mechanism allows for the normal expansion of the brain and 
soft tissues during infancy and childhood since a newborn has only forty 
percent of her adult brain volume (Kabbani and Raghuveer, 2004). 
Craniosynostosis is caused by the premature fusion of sutures and this 
can have detrimental effects on the child’s intelligence since brain growth 
is restricted. The disease also results in an abnormal head shape and an 
increase in intracranial pressure that often has devastating physiological 
consequences (Morris-Kay and Wilkie, 2005). The recent discovery of 
mutations in FGFR1, FGFR2, and FGFR3 in several cases of 
craniosynostosis has led to the hypothesis that the disease involves the 
failure of the fibroblast growth factor signaling system (Morriss-Kay and 
Wilkie, 2005). Furthermore, previous research has shown that zebrafish 
deficient in fgf20a exhibit several craniofacial defects that are similar in 
presentation to the defects seen in individuals with craniosynostosis 
(Albertson, unpublished data).  
The objectives of our research are to identify the anatomical 
consequences when fgf20a is absent, determine at what stage of 
development the defect arises, and to gain a better understanding of the 
mechanisms that lead to the defect. Essentially, we want to answer the 
questions, What?, When?, and How?.   
 We chose zebrafish (Danio rerio) as our model system to study 
craniofacial defects because the anatomy of the zebrafish cranial vault 
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and suture patterning is similar to that of mammalian organisms. In fact, 
the five major cranial sutures present in humans, metopic, sagittal, 
coronal, lambdoid, and squasomal, are also found in zebrafish. Also, 
zebrafish produce a large number of embryos that are transparent and 
develop externally. We can therefore analyze their phenotypic traits 
without using invasive techniques, and their genetics are easily 
manipulated.  
Previous research in mice has shown that a broad repertoire of 
Fgfs is expressed in the cranial sutures including fibroblast growth factor 
20a (Hajihosseini et al. 2001). Furthermore, recent studies in zebrafish 
have shown that when fgf20a is absent there are several phenotypic 
consequences including an irregular shape of the skull (Albertson, 
unpublished data). Zebrafish that are deficient in fgf20a are known as 
devoid of blastema, dob, mutants because of their inability to regenerate 
their tail due to the loss of blastema cells.  A blastema is a mass of cells 
that are undifferentiated and, thus, are capable of regenerating tissues 
and organs (including the tail fin in fish).  
  Previous research has also revealed that craniosynostosis is linked 
to fibroblast growth factor receptors, but little is known about the signal 
molecules, ligands, that bind to the receptor to trigger the cells to 
proliferate, differentiate, and/or migrate (Hajihosseini et al. 2001). Thus, in 
an effort to identify one of the cognate ligands, we examined the 
expression pattern of fgf20a in the developing zebrafish craniofacial 
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skeleton using whole mount in situ hybridization (WMISH) methods.  
   In our study, we amplified the fgf20a DNA sequence using 
Polymerase Chain Reaction (PCR), and then used a restriction enzyme 
that recognized the mutated form of the gene to cut this sequence in 
mutant animals. In this way we could identify animals that lacked a 
functional copy of the gene. Then, once we identified the dob mutants, we 
used advanced microscopic imaging to characterize the phenotypic 
consequences of the mutation, which included an expanded frontal region 
of the skull and aberrant suture patterning.  
We used whole mount in situ hybridization to localize fgf20a mRNA 
to particular regions of the developing skull in wild-type zebrafish. A 
synthesized mRNA complementary strand with a purple label was used to 
bind to the target sequence in situ. Thus, we were able to determine 
where the gene is normally expressed in the developing craniofacial 
skeleton.  
Our research results suggest that fibroblast growth factor 20a 
directly affects suture and skull development. We have demonstrated this 
in two ways. Firstly, in the absence of a fully functional fgf20a gene 
zebrafish have abnormal suture patterning. Secondly, we have shown that 
the fgf20a gene is normally expressed in the cranial sutures through the 
WMISH methods. The next step will be to determine when this aberrant 
suture pattern arises in the dob mutant. The future direction of this 
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research will include comparing the craniofacial development in wild-type 
and dob mutant zebrafish at different stages of development.  
Our results are important because this is the first instance where an 
fgf ligand is implicated in craniosynostosis. Furthermore, we have 
established a molecular foothold (via fgf20a) into skull and suture 
development, and we have established a model system for studying 
developmental origins and mechanisms of craniosynostosis. 
 
